Companies Like Nurix Therapeutics (NASDAQ:NRIX) Are In A Position To Invest In Growth

Simply Wall StOct 31 07:24 ET

Nurix Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswireOct 31 07:00 ET

UBS Launches SMID Cap Biotechs With Cancer, Autoimmunity in Focus

Seeking AlphaOct 24 15:32 ET

Express News | UBS Initiates Coverage On Nurix Therapeutics With Buy Rating, Announces Price Target of $35

BenzingaOct 24 07:46 ET

Barclays Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $31

Moomoo NewsOct 23 06:31 ET · Ratings

Nurix Therapeutics Announces Presentations at the 7th Annual TPD & Induced Proximity Summit

GlobeNewswireOct 21 16:00 ET